Previous 10 | Next 10 |
2023-06-27 07:15:00 ET Summary Inovio faces an uphill battle in turning around its performance as it closes out its first full year under new management. The company has made progress with its INO-3107 therapy for recurrent respiratory papillomatosis, receiving positive feedback f...
2023-06-09 10:17:07 ET Inovio Pharmaceuticals, Inc. (INO) Jefferies Healthcare Conference 2023 June 09, 2023 08:00 PM ET Company Participants Jacqueline Shea - President & CEO Michael Sumner - CMO Conference Call Participants Roger Song - Jefferies ...
INOVIO to Present at the 2023 Jefferies Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa. , May 25, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people f...
2023-05-24 13:57:04 ET The Russell 3000 index will have a new look on June 26, after the market opens, when 286 securities will be added and 179 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added an...
2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...
2023-05-23 16:34:26 ET The European Commission has granted Orphan Drug designation to Inovio Pharmaceuticals' ( NASDAQ: INO ) INO-3107 for recurrent respiratory papillomatosis. The monoclonal antibody is designed to provoke a targeted T cell response against HPV-6 and ...
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission PR Newswire PLYMOUTH MEETING, Pa. , May 23, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on d...
2023-05-17 18:55:23 ET Inovio Pharmaceuticals, Inc. (INO) 2023 RBC Capital Markets Global Healthcare Conference May 16, 2023, 04:05 PM ET Company Participants Greg Renza - Biotechnology Equity Research Analyst, RBC Conference Call Participants Jacqueline Shea...
Inseego Corp., a leader in 5G edge cloud solutions, today announced the launch of the next-generation 5G indoor router FX3100, with UScellular. The new upgraded FX3100, which includes the Qualcomm® Snapdragon™ X62 5G Modem-RF System, adds new capabilities to the current generation FX2...
2023-05-11 03:30:51 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2023 Earnings Call May 10, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q1 2023 Earnings ...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...